Study Finds Price Of Long-Acting PrEP Makes Population-Level HIV Control “Unrealistic”

Healio (9/8, Feller) reported, “The ‘unrealistic’ pricing of long-acting injectable PrEP hinders its use where HIV control budgets are stretched, according to researchers, who found that event-driven oral PrEP is a more cost-effective option for fixed bud...